ARCHIVES

FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

Strict System For Protection Of Human Subjects Ordered In Wake Of NIH Investigation

August 9, 1991

Avon Gives $3 Million To Expand CDC’s Screening Program

February 18, 1994

FOLFOX4 Improved PFS In Colorectal Cancer

April 25, 2008

Drugs and Targets: Akynzeo approved for chemotherapy-related nausea

October 10, 2014

Senate To NCI: Return To Old Guidelines, Stop “Mixed Messages” On Mammography

February 14, 1997

Minorities Increasingly Involved In Research, Training Programs

December 5, 1986